(19)

(11)

EP 2 571 541 A2

(12)

(88) Date of publication A3: 05.01.2012 (43) Date of publication: 27.03.2013 Bulletin 2013/13 (21) Application number: 11780289.2 (22) Date of filing: 09.05.2011

(51) International Patent Classification (IPC):  A61L 15/46(2006.01) A61K 9/00(2006.01) A61P 15/02(2006.01) B65B 55/18(2006.01) A61K 33/00(2006.01) A61L 29/16(2006.01) B01J 3/00(2006.01) C01B 21/22(2006.01) (86) International application number: PCT/IB2011/052032 (87) International publication number: WO 2011/141863 (17.11.2011 Gazette 2011/46)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR (30) Priority: 06.07.2010 US 361688 P 10.05.2010 US 333027 P (71) Applicant: Enox Biopharma, Inc. Vancouver, British Columbia V6J1X2 (CA)	(72) Inventors: AV-GAY, Yossef West Vancouver British Columbia V6R-2S9 (CA) MILLER, Christopher C. N. Vancouver British Columbia V7G 1B8 (CA) BOHBOT, Deborah Vancouver British Columbia V6R 2S9 (CA) REGEV-SHOSHANI, Gilly W.Vancouver British Columbia V6J2J8 (CA) (74) Representative: Dennemeyer & Associates S.A.  55, rue des Bruyères 1274 Howald 1274 Howald (LU)